Source:http://linkedlifedata.com/resource/pubmed/id/16669545
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-5-3
|
pubmed:abstractText |
The stress of critical illness evokes insulin resistance and hyperglycemia. Artificial nutrition is commonly considered one of the main causes of hyperglycemia in hospitalized patients. Patients with newly diagnosed hyperglycemia had a significantly higher mortality rate and a lower functional outcome than patients with a known history of diabetes or normoglycemia Intensive insulin treatment to normalize blood glucose during feeding has been shown to improve morbidity and mortality in patients in intensive care. Insulin glargine may contribute to improving the glycemic values in patients receiving artificial nutrition with hyperglycemia.
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-9074
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16669545-Critical Illness,
pubmed-meshheading:16669545-Humans,
pubmed-meshheading:16669545-Hyperglycemia,
pubmed-meshheading:16669545-Hypoglycemic Agents,
pubmed-meshheading:16669545-Insulin,
pubmed-meshheading:16669545-Insulin, Long-Acting,
pubmed-meshheading:16669545-Insulin Resistance,
pubmed-meshheading:16669545-Intensive Care,
pubmed-meshheading:16669545-Parenteral Nutrition, Total
|
pubmed:articleTitle |
[Artificial nutrition in the patient with hyperglycemia].
|
pubmed:publicationType |
Editorial,
English Abstract
|